PTA Balloon: Balloon Angioplasty

DEVICE2 trials

Sponsors

Medtronic Endovascular

Conditions

Femoral Artery OcclusionFemoral Artery StenosisPeripheral Arterial Disease (PAD)Popliteal Artery OcclusionPopliteal Artery Stenosis

Unknown Phase

Randomized Trial of IN.PACT Admiral® Drug Coated Balloon vs Standard PTA for the Treatment of SFA and Proximal Popliteal Arterial Disease

CompletedNCT01175850

Medtronic EndovascularPeripheral Arterial Disease (PAD)

Start: 2010-09-30End: 2017-04-30Updated: 2017-05-16

IN.PACT Admiral Drug-Coated Balloon vs. Standard Balloon Angioplasty for the Treatment of Superficial Femoral Artery (SFA) and Proximal Popliteal Artery (PPA)

CompletedNCT01566461

Medtronic EndovascularFemoral Artery Occlusion, Femoral Artery Stenosis, Popliteal Artery Occlusion +1

Start: 2012-03-31End: 2018-05-31Updated: 2019-02-12

Related Papers

Determinants of Drug-Coated Balloon Failure in Patients Undergoing Femoropopliteal Arterial Intervention

Journal of the American College of Cardiology2022-09-0125 citations

Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions

Circulation Cardiovascular Interventions2019-06-01170 citations

Mortality Not Correlated With Paclitaxel Exposure: An Independent Patient-Level Meta-Analysis of a Drug-Coated Balloon.

2019-01-25164 citations

Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries

Circulation Cardiovascular Interventions2018-01-01213 citations

Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA.

2015-10-14265 citations

Drug-Coated Balloon Versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease

Circulation2014-12-04650 citations